Dr. Lambert Edelmann brings extensive business development expertise to Cell One Partners, leveraging his deep experience in the life sciences sector. He advises on strategies, identifies market opportunities, develops marketing campaigns, licenses technologies, initiates partnerships, and negotiates agreements. Dr. Edelmann’s role also includes deal structuring, capital raising, and driving growth and innovation.

 

At Click Therapeutics and PTC Therapeutics, he analyzed business landscapes, identified opportunities, managed external partnerships, and represented the companies at key industry events. He facilitated alliance activities, coordinated stakeholders, and negotiated collaboration agreements, enabling the discovery and development of drugs including small molecules and biologics. Previously, at Synubi Pharmaceuticals, he played a key role in corporate formation, IP management, business strategy development, in presenting to venture capitalists, pharmaceutical companies, potential investors, and partners.

 

At the New York Blood Center, Dr. Edelmann launched a successful marketing campaign for B2B services in cell therapy manufacturing and strategic research alliances. He executed over 80 agreements, including licenses, MOUs, and collaboration agreements. At Mount Sinai Innovation Partners, and at Partners Innovation at Harvard University, he developed business strategies, managed patent portfolios, conducted IP audits, and has been instrumental in advancing numerous life science innovations. Dr. Edelmann’s ability to assess business opportunities and drive partnerships makes him a vital asset to Cell One Partners.